Oak Review (2026)
By Alexandru Vieru · Founder & Editor · Not medical advice
Independently researched · scored on our public 4-criteria methodology
A low-priced, longevity-minded option — compounded semaglutide from $119/mo and tirzepatide from $199/mo, after an async licensed-provider review, with free shipping, health coaching and optional NAD+/peptide add-ons.
Visit Oak →Summarize this page with
Short answer
Oak scores 7.7/10 (#4 of 30 clinics). $119/mo is the same regardless of medication or dose, but Oak's own page doesn't spell out the commitment behind that number.
Our verdict
Oak earns 7.7/10 and ranks #4 of 30online GLP-1 clinics we've scored. A low-priced, longevity-minded option — compounded semaglutide from $119/mo and tirzepatide from $199/mo, after an async licensed-provider review, with free shipping, health coaching and optional NAD+/peptide add-ons.
Commercial partner. We may earn a commission if you sign up with Oak through a link on this page. It buys placement in our links, never in the ranking: the score comes from the published rubric and the commission is not one of its inputs.
Pricing details
$119/mo is the same regardless of medication or dose, but Oak's own page doesn't spell out the commitment behind that number.
$119/mo is the site's own FAQ wording ("programs start at as little as $119/month") — plan length and promo terms behind that figure aren't itemized on the homepage.
Classified as “Flat at every dose” — see how we classify every clinic's price →
Sources: Pricing verified on oaklovesyou.com
Is Oak legit?
What we checked before publishing this page.
- ✓ A U.S.-licensed clinician reviews your case before anything is prescribed
- ✓ Intake includes a real medical questionnaire, not a rubber stamp
- ✓ Named price on their own site ($119/mo), verified 2026-09-14
- ✓ Ranked by the rubric on our editorial policy page — payout status never enters into it
Independently verified on Trustpilot: 4.4/5 from 54 reviews (checked 2026-08-30). 11 of those (20%) are from the last 12 months — a rating resting mostly on old reviews reads differently than one built on recent ones. See reviews →
What the research says
Dr. Daniel J. Drucker (Lunenfeld-Tanenbaum Research Institute, University of Toronto — co-discoverer of GLP-1 biology) reviewed the expanding evidence base for GLP-1 medicines beyond weight loss, including cardiovascular and kidney-disease benefit, alongside open questions on long-term safety that still require more data.
“GLP-1-based therapies for diabetes, obesity and beyond,” Nature Reviews Drug Discovery / Nature Medicine, 2025. More on GLP-1 safety →
Sources: Trustpilot
Third-party records
What we found outside Oak's own site — BBB, its named pharmacy partner (or lack of one), and whether it publishes a real HIPAA notice.
Better Business Bureau
No BBB profile found for Oak (checked 2026-08-30).
No BBB profile found for Oak / Oak Longevity Holdings Corp.
Pharmacy partner
Oak does not name the specific pharmacy that fills or compounds its medications (checked privacy policy, 2026-08-30). That is the norm for this category, not unusual for Oak specifically — most providers we've checked don't name one either. Discloses pharmacy services generically ("health care providers...including pharmacy services") — no pharmacy named.
HIPAA disclosure
Not found — checked 2026-08-30. Privacy policy explicitly states it does NOT cover PHI and that a separate "Oak Notice of Privacy Practices" exists for that — but that document isn't linked from this page, so we couldn't verify it actually contains real HIPAA disclosures. Referencing a notice you don't link to isn't the same as publishing one.
Who operates it
Operated by Leaf Longevity Holdings Corp. — published on Oak's own site, checked 2026-09-14. Published as “Leaf Longevity Holdings Corp. DBA Oak Longevity”. No address anywhere on the site.
Cancelling and refunds
No written cancellation or refund terms found on the site (checked 2026-09-14). A “cancel anytime” claim appears, but no written terms — no notice period, no fee schedule, nothing on partially used periods. The policy sits behind a footer link that does not render its text on the pages where the price is quoted.
20 of the 23 clinics we could read publish no written cancellation terms. We read all 25 and quoted what they say →
Sources: Privacy policy
Choose Oak if
- + You want this kind of clinic
- + You're looking for compounded semaglutide
- + You're looking for compounded tirzepatide
Skip Oak if
- − Transparency & Trust scores lower (7.0/10)
- − Clinical Oversight scores lower (7.5/10)
- − Medication Options scores lower (8.0/10)
Oak pros & cons
What we like
- + One of the cheapest entries we track ($119/mo semaglutide)
- + Needle-free oral route plus NAD+ and longevity add-ons
- + Licensed-provider review (no video call), free shipping, no subscription lock-in
What could be better
- − Transparency & Trust scores lower (7.0/10)
- − Clinical Oversight scores lower (7.5/10)
- − Medication Options scores lower (8.0/10)
Quick facts
| Our score | 7.7/10 |
| Starting price | $119/mo |
| Treatment types | compounded semaglutide, compounded tirzepatide, oral / sublingual, oral drops |
| Availability | Not published — check before you sign up |
| Insurance | Typically cash-pay (HSA/FSA often eligible) |
| Overall rank | #4 of 30 |
| Price status | Verified 2026-09-14 |
Score breakdown
Sources: Full scoring methodology
How we know — the evidence behind this score
Every criterion below shows what we checked, when, and where you can check it yourself. Where we have no public source on file, the row says so rather than implying one exists — 1 of 4 criteria here is backed by a source you can open.
| Criterion | Score | Last checked | Source you can open |
|---|---|---|---|
| Price & Value (25%) | 8.5frozen | 2026-09-14 | oaklovesyou.com |
| Clinical Oversight (30%) | 7.5 | — | no public source on file |
| Medication Options (20%) | 8.0 | — | no public source on file |
| Transparency & Trust (25%) | 7.0 | — | no public source on file |
Frozen score. One criterion above is marked frozen (since 2026-09-01): the rule used to produce the value assumed a confirmed ongoing price, and that assumption does not hold for this clinic. We are leaving the number visible and flagged rather than quietly recalculating it. How scoring works →
How Oak works
- 1. Online intake. Complete a medical questionnaire and eligibility check (often BMI-based) covering your health history.
- 2. Clinician review. A licensed clinician reviews your information and, if appropriate, prescribes semaglutide or tirzepatide with a dose-titration plan.
- 3. Delivery & monitoring. Your medication ships discreetly to your door, with check-ins and dose adjustments along the way.
Frequently asked questions
How much does Oak cost?
Oak starts at $119/mo (verified 2026-09-14). Final cost depends on your medication and dose.
Does Oak take insurance?
Like most online GLP-1 clinics, Oak generally operates cash-pay, though HSA/FSA funds are often eligible. Confirm directly at checkout.
How do I qualify for online GLP-1 treatment?
You complete a medical questionnaire and eligibility check (often BMI-based). A licensed clinician reviews it and, if appropriate, prescribes semaglutide or tirzepatide — there's no questionnaire-only prescription without clinician review.
Is Oak available in my state?
Oak does not publish a state-by-state availability list we could verify, so we do not claim one. Confirm with the clinic before you pay. Telehealth availability and shipping can vary by state.
Alternatives to Oak
Helpful tools
Compare Oak vs other clinics
Ready to get started with Oak?
7.7/10 · from $119/mo · Not published — check before you sign up
Get Started →Top picks
Alexandru Vieru · Founder & Editor
Alexandru Vieru founded and edits MyGLP1 Guides, and personally re-checks every price, medication list and refund policy the site publishes before it goes live — that's what feeds the site's 4-criteria, 1-to-10 rubric. He holds no medical license, so any clinical fact on this site traces back to something citable — an FDA page, a manufacturer's own label, a peer-reviewed paper — never his own judgment.
Price status: Verified 2026-09-14.Scores are derived from our documented methodology and are never influenced by affiliate commissions. “Visit” links may be affiliate links that support our work. Educational information only — not medical advice.